Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/antengene-granted-ind-approval-in-china-for-the-phase-ib-study-of-atg-008-onatasertib-in-combination-with-atg-010-selinexor-in-patients-with-diffuse-large-b-cell-lymphoma-301413468.html

PRNEWSWIRE
01 Nov 2021